8-KEarnings & ResultsExhibits & Filings

CVS HEALTH Corp 8-K Report, Financial Results (Feb 6, 2013)

Filed February 6, 2013For Securities:CVS

Summary

CVS Caremark Corporation (CVS) filed an 8-K on February 6, 2013, to report its fourth quarter and full-year financial results for the period ending December 31, 2012. The filing primarily serves to attach the official press release detailing these earnings. While the 8-K itself doesn't contain the full financial data, it signifies the company's public disclosure of its performance for the mentioned periods. Investors should refer to the attached press release (Exhibit 99.1) for specific details on revenue, earnings per share, and other key financial metrics. This filing acts as the formal notification of these results and marks the point from which the information becomes officially available for public and investor analysis. The Chief Financial Officer, David M. Denton, signed off on the filing, underscoring the importance of these financial disclosures.

Key Highlights

  • 1Form 8-K filed on February 6, 2013, by CVS Caremark Corporation.
  • 2The filing announces the company's earnings for the fourth quarter and full year ended December 31, 2012.
  • 3Exhibit 99.1 contains the press release with the detailed financial results.
  • 4This report is furnished, not filed, meaning it won't be automatically incorporated into future registration statements unless explicitly stated.
  • 5The filing was signed by David M. Denton, Executive Vice President and Chief Financial Officer.
  • 6This 8-K serves as the official notification of CVS's year-end and Q4 2012 financial performance.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to CVS Caremark Corporation's earnings results for the fourth quarter and the full year ended December 31, 2012, through an attached press release.

The specific financial details are contained within the press release dated February 6, 2013, which is attached as Exhibit 99.1 to this 8-K filing.

The information in this report, specifically the earnings release, is being furnished, not filed. This means it is being provided to the SEC but will not automatically be incorporated into other SEC filings like registration statements unless specifically referenced.

David M. Denton is the Executive Vice President and Chief Financial Officer of CVS Caremark Corporation. His signature on the filing confirms that the company is officially releasing this information and that it has been reviewed and authorized by senior financial leadership.